Gli family transcription factors are drivers of patupilone resistance in ovarian cancer

Biochemical Pharmacology

Volumn 84, Issue 11, 2012, Pages 1409-1418

  Mozzetti, Simona ^a   Martinelli, Enrica ^a   Raspaglio, Giuseppina ^a   Prislei, Silvia ^a   De Donato, Marta ^a   Filippetti, Flavia ^a   Shahabi, Shohreh ^b   Scambia, Giovanni ^a,c   Ferlini, Cristiano ^b,c  

^a CATHOLIC UNIVERSITY   (Italy)

^b DANBURY HOSPITAL   (United States)

^c Jean Paul IInd Research Foundation   (Italy)

Author keywords

Drug resistance; Epothilones; Gli inhibitors; Gli1; Gli2; Gli3; Patupilone

Indexed keywords

EPOTHILONE B; SCATTER FACTOR; TRANSCRIPTION FACTOR GLI1;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER RESISTANCE; GENE SILENCING; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; OVARY CANCER; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DNA PRIMERS; DRUG RESISTANCE, NEOPLASM; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL-MESENCHYMAL TRANSITION; EPOTHILONES; FEMALE; HUMANS; OVARIAN NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

EID: 84868482683     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2012.08.019     Document Type: Article

References (32)

1. R.J. Kowalski, P. Giannakakou, and E. Hamel Activities of the microtubule-stabilizing agents epothilones A and B with purified tubulin and in cells resistant to paclitaxel (Taxol(R)) J Biol Chem 272 1997 2534 2541
2. F.Y. Lee, R. Smykla, K. Johnston, K. Menard, K. McGlinchey, and R.W. Peterson Preclinical efficacy spectrum and pharmacokinetics of ixabepilone Cancer Chemother Pharmacol 63 2009 201 212
3. P.W. Ingham Hedgehog signaling: a tale of two lipids Science 294 2001 1879 1881
4. B. Stecca, and I.A.A. Ruiz Context-dependent regulation of the GLI code in cancer by HEDGEHOG and non-HEDGEHOG signals J Mol Cell Biol 2 2010 84 95
5. M. Evangelista, H. Tian, and F.J. de Sauvage The hedgehog signaling pathway in cancer Clin Cancer Res 12 2006 5924 5928
6. R. Bhattacharya, J. Kwon, B. Ali, E. Wang, S. Patra, and V. Shridhar Role of hedgehog signaling in ovarian cancer Clin Cancer Res 14 2008 7659 7666
7. X. Chen, A. Horiuchi, N. Kikuchi, R. Osada, J. Yoshida, and T. Shiozawa Hedgehog signal pathway is activated in ovarian carcinomas, correlating with cell proliferation: it's inhibition leads to growth suppression and apoptosis Cancer Sci 98 2007 68 76
8. H. Kajiyama, K. Shibata, M. Terauchi, M. Yamashita, K. Ino, and A. Nawa Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells Int J Oncol 31 2007 277 283
9. Kean S. Medicine Disrupting Hedgehog may reverse advanced cancer, if only temporarily Science 325 2009 1188
10. S. Mozzetti, R. Iantomasi, I. De Maria, S. Prislei, M. Mariani, and A. Camperchioli Molecular mechanisms of patupilone resistance Cancer Res 68 2008 10197 10204
11. C. Ferlini, G. Raspaglio, S. Mozzetti, M. Distefano, F. Filippetti, and E. Martinelli Bcl-2 down-regulation is a novel mechanism of paclitaxel resistance Mol Pharmacol 64 2003 51 58
12. S. Prislei, S. Mozzetti, F. Filippetti, M. De Donato, G. Raspaglio, and L. Cicchillitti From plasma membrane to cytoskeleton: a novel function for semaphorin 6A Mol Cancer Ther 7 2008 233 241
13. A. Ruiz i Altaba Gli proteins encode context-dependent positive and negative functions: implications for development and disease Development 126 1999 3205 3216
14. G. Raspaglio, F. Filippetti, S. Prislei, R. Penci, I. De Maria, and L. Cicchillitti Hypoxia induces class III beta-tubulin gene expression by HIF-1alpha binding to its 3' flanking region Gene 409 2008 100 108
15. D. Cui, Q. Xu, K. Wang, and X. Che Gli1 is a potential target for alleviating multidrug resistance of gliomas J Neurol Sci 288 2010 156 166
16. B.Z. Stanton, and L.F. Peng Small-molecule modulators of the Sonic Hedgehog signaling pathway Mol Biosyst 6 2010 44 54
17. S. Blaess, J.D. Corrales, and A.L. Joyner Sonic hedgehog regulates Gli activator and repressor functions with spatial and temporal precision in the mid/hindbrain region Development 133 2006 1799 1809
18. D. Vergara, B. Merlot, J.P. Lucot, P. Collinet, D. Vinatier, and I. Fournier Epithelial-mesenchymal transition in ovarian cancer Cancer Lett 291 2010 59 66
19. M.F. Bijlsma, A.P. Groot, J.P. Oduro, R.J. Franken, S.H. Schoenmakers, and M.P. Peppelenbosch Hypoxia induces a hedgehog response mediated by HIF-1alpha J Cell Mol Med 13 2009 2053 2060
20. H. Onishi, M. Kai, S. Odate, H. Iwasaki, Y. Morifuji, and T. Ogino Hypoxia activates the hedgehog signaling pathway in a ligand-independent manner by upregulation of Smo transcription in pancreatic cancer Cancer Sci 102 2011 1144 1150
21. J.A. Sparano, E. Vrdoljak, O. Rixe, B. Xu, A. Manikhas, and C. Medina Randomized phase III trial of ixabepilone plus capecitabine versus capecitabine in patients with metastatic breast cancer previously treated with an anthracycline and a taxane J Clin Oncol 28 2010 3256 3263
22. G. Ferrandina, M. Mariani, M. Andreoli, S. Shahabi, G. Scambia, and C. Ferlini Novel drugs targeting microtubules: the role of epothilones Curr Pharm Des 18 2012 2793 2803
23. N.A. Riobo, K. Lu, and C.P. Emerson Jr. Hedgehog signal transduction: signal integration and cross talk in development and cancer Cell Cycle 5 2006 1612 1615
24. J. Sims-Mourtada, J.G. Izzo, S. Apisarnthanarax, T.T. Wu, U. Malhotra, and R. Luthra Hedgehog: an attribute to tumor regrowth after chemoradiotherapy and a target to improve radiation response Clin Cancer Res 12 2006 6565 6572
25. Y.J. Chen, J. Sims-Mourtada, J. Izzo, and K.S. Chao Targeting the hedgehog pathway to mitigate treatment resistance Cell Cycle 6 2007 1826 1830
26. R.R. Singh, K. Kunkalla, C. Qu, E. Schlette, S.S. Neelapu, and F. Samaniego ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma Oncogene 30 2011 4874 4886
27. X. Li, W. Deng, C.D. Nail, S.K. Bailey, M.H. Kraus, and J.M. Ruppert Snail induction is an early response to Gli1 that determines the efficiency of epithelial transformation Oncogene 25 2006 609 621
28. Y. Katoh, and M. Katoh Hedgehog signaling, epithelial-to-mesenchymal transition and miRNA (review) Int J Mol Med 22 2008 271 275
29. A. Latifi, K. Abubaker, N. Castrechini, A.C. Ward, C. Liongue, and F. Dobill Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile J Cell Biochem 112 2011 2850 2864
30. Y.L. Pon, H.Y. Zhou, A.N. Cheung, H.Y. Ngan, and A.S. Wong p70 S6 kinase promotes epithelial to mesenchymal transition through snail induction in ovarian cancer cells Cancer Res 68 2008 6524 6532
31. P. Seve, and C. Dumontet Is class III beta-tubulin a predictive factor in patients receiving tubulin-binding agents Lancet Oncol 9 2008 168 175
32. G. Ferrandina, G.F. Zannoni, E. Martinelli, A. Paglia, V. Gallotta, and S. Mozzetti Class III beta-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients Clin Cancer Res 12 2006 2774 2779